Roche halts lung cancer immunotherapy trial due to latest setback
![](https://4gi.tv/wp-content/uploads/2024/07/0807-ws-he2-1024x576.webp)
Roche will halt a trial of a new immunotherapy for lung cancer after the drug failed to show benefits over Merck & Co’s established treatment Keytruda, casting further doubt on the promise of a drug pioneered by the Swiss company.
POPULAR POSTS
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-env2.jpg)
Pope Francis calls for action on climate change
September 6, 2024
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-env1.jpg)
Climate change costing Africa up to 5% of GDP, UN says
September 6, 2024
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-env.jpg)
A forest fire has destroyed 20% of the forests in Brazil
September 6, 2024
![](https://4gi.tv/wp-content/uploads/2024/09/0609-ws-cul2.jpg)
Toronto Film Festival showcases an industry transformed by streaming
September 6, 2024
LIVE STREAM